HealthTree Podcast for Myeloma

HealthTree Podcast for Myeloma

HealthTree Podcast for Multiple Myeloma (formerly known as Myeloma Crowd Radio) is an hour-long podcast series of patient-led interviews with top multiple myeloma experts. This was the very first program created by the HealthTree Foundation for Multiple Myeloma (Myeloma Crowd).

A majority of the interviews focus on learning about an open multiple myeloma clinical trial: who is eligible, what is the treatment, and how the trial can benefit you.

During each show, we are focused on simplifying the conversation and asking patient questions about the topic so the doctor can explain the subject in patient-friendly-language.

At the end of the interview, the show is opened up to listener questions and anyone is welcome to dial-in and ask questions about what was discussed.

Over 2 million people have listened to over 155 HealthTree Podcast for Multiple Myeloma Episodes.

Full Show: Mid-Year Myeloma Update with Paul Richardson, MD, Dana Farber Cancer Institute

August 02, 2022

Paul Richardson, MD of the Dana Farber Cancer Institute joins the HealthTree Podcast for multiple myeloma for a mid-year update

Full Show: An Allo CAR T Myeloma Review with Jesus Berdeja, MD, Sarah Cannon Research Institute

July 07, 2022

Learn more about allogeneic ("off-the-shelf") CAR T therapies in development with CAR T expert Jesus Berdeja, MD

Full Show: Looking Forward into 2022 in Multiple Myeloma With Robert Orlowski, MD, PHD, MD Anderson Cancer Center

March 09, 2022

What can myeloma patients expect to see in 2022 for multiple myeloma therapy? Join this overall review of the myeloma landscape on Myeloma Crowd Radio with Dr. Robert Orlowski, MD, PhD, of MD Anderson Cancer Center.

Full Show: Engineered Toxin Bodies Targeting CD38 in Myeloma with Shaji Kumar, MD, Mayo Clinic

January 25, 2022

A new treatment called Engineered Toxin Bodies is in development in multiple myeloma. Learn more with Dr. Shaji Kumar.

Full Show: Tasquinimod As a New Myeloma Therapy with Dan Vogl, MD and Yulia Nefedova, MD, PhD

January 19, 2022

A new treatment is in early myeloma clinical trials testing tasquinimod to treat roque immune cells called MDSCs. Learn more in this informative show with Drs. Dan Vogl and Yulia Nefedova.

Full Show: A Smoldering Myeloma Update with Elisabet Manasanch, MD, MD Anderson Cancer Center

November 21, 2021

A smoldering myeloma update with Elisabet Manasanch, MD of MD Anderson Cancer Center

Full Show: Managing Keratopathy for Patients on BLENREP with Cristina Gasparetto, MD and Mark Newman, OD

October 25, 2021

BLENREP is a new myeloma drug targeting BCMA. Learn how to manage the side effect called keratopathy while using it.

Full Show: Using Monoclonal Antibodies in Newly Diagnosed Multiple Myeloma with Peter Voorhees, MD, Levine Cancer Institute

June 09, 2021

Learn how monoclonal antibodies are being used for newly diagnosed myeloma in this interesting show with Peter Voorhees, MD of the Levine Cancer Institute.

Full Show: Treating Amyloidosis with Sascha Tuchman, MD, University of North Carolina

June 01, 2021

AL Amyloidosis is a condition that can occur with multiple myeloma. Learn from amyloidosis and myeloma expert Dr. Sascha Tuchman on Myeloma Crowd Radio about signs, symptoms and the latest treatment.

Full Show: The New Abecma (ide-cel) CAR T FDA Approval in Multiple Myeloma with Dr. Noopur Raje, Mass General

April 27, 2021

Now that Abecma (CAR T therapy) is approved in multiple myeloma, learn more about who is eligible and when you may want to consider using it after four prior lines of therapy.